Evidence map›Paper›PMID 26324252›Full record

ArticleJournal of occupational rehabilitation2016

Course of Depressive Symptoms Following a Workplace Injury: A 12-Month Follow-Up Update.

Nancy Carnide, Renée-Louise Franche, Sheilah Hogg-Johnson, Pierre Côté, F Curtis Breslin, Colette N Severin, Ute Bültmann, Niklas Krause

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of occupational rehabilitation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Experiences, impacts and service needs of injured and ill workers in the WSIB process: evidence from Thunder Bay and District (Ontario, Canada).Health promotion and chronic disease prevention in Canada : research, policy and practice · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Nancy CarnideInstitute for Work & Health, 481 University Avenue, Suite 800, Toronto, ON, M5G 2E9, Canada. ncarnide@iwh.on.ca.
Renée-Louise FrancheInstitute for Work & Health, 481 University Avenue, Suite 800, Toronto, ON, M5G 2E9, Canada.
Sheilah Hogg-JohnsonInstitute for Work & Health, 481 University Avenue, Suite 800, Toronto, ON, M5G 2E9, Canada.
Pierre CôtéDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
F Curtis BreslinInstitute for Work & Health, 481 University Avenue, Suite 800, Toronto, ON, M5G 2E9, Canada.
Colette N SeverinInstitute for Work & Health, 481 University Avenue, Suite 800, Toronto, ON, M5G 2E9, Canada.
Ute BültmannInstitute for Work & Health, 481 University Avenue, Suite 800, Toronto, ON, M5G 2E9, Canada.
Niklas KrauseDepartment of Environmental Health Sciences and Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA.
Institute for Work & Health · CAPublic Health Ontario · CAUniversity Medical Center Groningen · NLUniversity of California, Los Angeles · USUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction To estimate the prevalence, incidence and course of depressive symptoms, their relationship with return-to-work, and prevalence of depression diagnosis/treatment 12 months following a lost-time workplace musculoskeletal injury. Methods In a prospective cohort study, 332 workers' compensation claimants with a back or upper extremity musculoskeletal disorder completed interviews at 1, 6 and 12 months post-injury. Participants self-reported they had not received a depression diagnosis 1 year pre-injury. Cutoff of 16 on the CES-D defined a high level of depressive symptoms. Self-reported data on depression diagnosis and treatment and work status since injury were collected. Results Cumulative incidence of high depressive symptom levels over 12 months was 50.3 % (95 % CI 44.9-55.7 %). At 12 months, 24.7 % (95 % CI 20.1-29.3 %) of workers exhibited high levels. Over 12 months, 49.7 % (95 % CI 44.3-55.1 %) had low levels at all 3 interviews, 14.5 % (95 % CI 10.7-18.2 %) had persistently high levels, and 25.6 % (95 % CI 20.9-30.3 %) demonstrated improvements. Among workers with low baseline levels, incidence of high levels at 12 months was 6.0 % (95 % CI 2.7-9.3 %). For workers with high baseline levels, 36.1 % (95 % CI 27.9-44.3 %) exhibited persistent high symptoms at 6 and 12 months, while 38.4 % (95 % CI 30.1-46.6 %) experienced low levels at 6 and 12 months. Problematic RTW outcomes were common among workers with a poor depressive symptom course. Among workers with persistent high symptoms, 18.8 % (95 % CI 7.7-29.8 %) self-reported receiving a depression diagnosis by 12 months and 29.2 % (95 % CI 16.3-42.0 %) were receiving treatment at 12 months. Conclusions Depressive symptoms are common in the first year following a lost-time musculoskeletal injury and a poor depressive symptom course is associated with problematic RTW outcomes 12 months post-injury. While symptoms appear to improve over time, the first 6 months appear to be important in establishing future symptom levels and may represent a window of opportunity for early screening.

Indexed as

Return to WorkAccidents, OccupationalAdultCanadaDepressionDepressive DisorderFemaleFollow-Up StudiesHumansIncidenceMaleMiddle AgedMusculoskeletal DiseasesOccupational InjuriesPrevalenceProspective StudiesDepressionOccupational injuriesWorkers’ compensation

Identifiers

PMID26324252
OpenAlexW1249476433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.